We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KEY:TSXKeyera Corp. Analysis

Data as of 2026-05-28 - not real-time

CA$56.91

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Keyera (KEY) is trading at $56.91, comfortably above its 20‑day SMA of $54.38 and its 50‑day SMA of $52.98, while the 200‑day SMA sits near $47.35, underscoring a clear bullish trend. The MACD line (1.71) sits above the signal line (1.38) and the histogram is positive, reinforcing momentum, and the RSI of 60.6 suggests the stock is not yet overbought. Volume is on an increasing trajectory, adding confidence to the technical upside. However, the valuation metrics tell a different story: a trailing PE of 72.0x dwarfs the industry average of 20.7x, even though the forward PE contracts to 18.3x, indicating that earnings are expected to improve. The DCF‑derived fair value of $6.79 versus the market price points to a substantial premium, yet the model‑based upside of only 5.8% tempers expectations. The dividend yield of 3.8% looks attractive, but a payout ratio of 270% raises sustainability concerns. The recent $5.3 billion acquisition of Plains’ Canadian NGL business expands the integrated NGL platform, offering long‑term growth potential but also introduces regulatory scrutiny, as the Competition Tribunal review is ongoing. Volatility remains high at 34.5%**30‑day** and beta is slightly negative (-0.31), reflecting sensitivity to broader market swings. Overall, the stock blends strong technical momentum with significant valuation headwinds and a dividend that may not be maintainable.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (SMA, MACD, RSI)
  • High current valuation relative to peers
  • Recent acquisition pending regulatory clearance

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward PE compression to 18.3x
  • Integration of Plains NGL assets expanding earnings base
  • Attractive dividend yield despite payout concerns

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strategic position in North‑American NGL midstream
  • Sustained cash‑flow generation but high leverage
  • Potential for dividend policy adjustment

Key Metrics & Analysis

Financial Health

Revenue Growth-26.10%
Profit Margin2.81%
P/E Ratio72.0
ROE6.71%
ROA3.24%
Debt/Equity249.10
P/B Ratio5.2
Op. Cash FlowCA$931.2M
Free Cash FlowCA$407.3M
Industry P/E20.7

Technical Analysis

TrendBullish
RSI60.6
SupportCA$48.60
ResistanceCA$59.14
MA 20CA$54.38
MA 50CA$52.98
MA 200CA$47.35
MACDBullish
VolumeIncreasing
Fear & Greed Index91.68

Valuation

Fair ValueCA$6.79
Target PriceCA$60.21
Upside/Downside5.81%
GradeOvervalued
TypeBlend
Dividend Yield3.80%

Risk Assessment

Beta-0.31
Volatility34.54%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.